Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-course Rifamycin Regimens for Latent TB in ESKD
NCT05021731Phase 4Not yet recruiting
- Start
- Apr 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of rifapentine in Tuberculosis (TB). Planned start Apr 2024; status: not yet recruiting.
02
Drugs
rifapentine
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT05021731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05021731.